1
Clinical Trials associated with Aspirin/Rosuvastatin Calcium/Prasugrel Hydrochloride / Not yet recruitingPhase 3IIT Polypill Strategy for the Treatment of Patients After Acute Coronary Syndromes - A Multicenter Randomized Controlled Trial
The current study aims to investigate whether combining the standard medications prescribed after acute coronary syndrome (ACS)-aspirin, P2Y12 inhibitors, and statins-into a single polypill can improve outcomes following an ACS event. Although these therapies are effective, gaps in adherence and uptake significantly contribute to risk or adverse events in the post-ACS period. This study is designed as a pragmatic, multi-center, randomized trial to assess the feasibility and effectiveness of a polypill-based strategy for treatment of ACS.
100 Clinical Results associated with Aspirin/Rosuvastatin Calcium/Prasugrel Hydrochloride
100 Translational Medicine associated with Aspirin/Rosuvastatin Calcium/Prasugrel Hydrochloride
100 Patents (Medical) associated with Aspirin/Rosuvastatin Calcium/Prasugrel Hydrochloride
100 Deals associated with Aspirin/Rosuvastatin Calcium/Prasugrel Hydrochloride